IndexIQ Advisors’s NuVasive, Inc. NUVA Stock Holding History

IndexIQ Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,134	Closed	-$233K	–	1356
2020 Q4	$233K	Buy	4,134 +427	+12%	+$21K	0.01%	844
2020 Q3	$180K	Buy	3,707 +200	+6%	+$10.8K	0.01%	727
2020 Q2	$195K	Sell	3,507 -246	-7%	-$14.2K	0.01%	608
2020 Q1	$190K	Buy	+3,753	New	+$252K	0.01%	439

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

IndexIQ Advisors's NUVA Position: Q1 2021 in Review

IndexIQ Advisors sold out of NuVasive, Inc. (NUVA) in Q1 2021, closing a stake of 4,134 shares — an estimated $233K sold.

IndexIQ Advisors first reported a position in NUVA in Q1 2020 and held it in 4 quarters. The position peaked at $233K in Q4 2020. 261 funds tracked by Wall St. Rank hold NUVA as of Q1 2021.

IndexIQ Advisors reported no remaining NuVasive, Inc. position as of Q1 2021 after selling out during the quarter.
IndexIQ Advisors sold 4,134 NuVasive, Inc. shares in Q1 2021, an estimated $233K.
IndexIQ Advisors first reported a position in NuVasive, Inc. in Q1 2020 and held it in 4 quarters.
IndexIQ Advisors's NuVasive, Inc. position peaked at $233K in Q4 2020.
261 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.